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AbstrACt
Objectives Every year, influenza poses a significant 
burden on the National Health Service in England. Influenza 
vaccination is an effective measure to prevent severe disease, 
hence, maximising vaccine coverage in the most vulnerable 
is a priority. We aimed to identify the extent to which 
socioeconomic status is associated with influenza-associated 
illness (IAI) and influenza vaccine coverage.
Design Retrospective observational study using hospital 
episode statistics.
setting Merseyside, North-West of England, including the 
city of Liverpool.
Participants Residents of Merseyside hospitalised with 
IAI between April 2004 and March 2016, and Merseyside 
general practice registered patients eligible for influenza 
vaccination in 2014/2015 and 2015/2016 influenza 
seasons.
Exposures Socioeconomic deprivation based on lower 
super output area English Indices of Deprivation scores.
Primary and secondary outcome measures Incidence 
and risk of IAI hospitalisation, and vaccine uptake.
results There were 89 058 hospitalisations related to 
IAI among Merseyside residents (mean yearly rate=4.9 
per 1000 population). Hospitalisations for IAI were more 
frequent in the most socioeconomically deprived areas 
compared with the least deprived in adults aged 15–39 
years (incidence rate ratio (IRR) 2.08;95% CI 1.76 to 
2.45; p<0.001), 60–64 years (IRR 2.65; 95% CI 2.35 
to 2.99; p<0.001) and 65+ years (IRR 1.90; 95% CI 
1.73 to 2.10; p<0.001), whereas rates in children were 
more homogeneous across deprivation strata. Vaccine 
uptake was lower than the nationally set targets in most 
neighbourhoods. The odds of vaccine uptake were 30% 
lower (OR 0.70; 95% CI 0.66 to 0.74; p<0.001) and 10% 
lower (OR 0.90; 95% CI 0.88 to 0.92; p<0.001) in the most 
socioeconomically deprived quintile compared with the 
least deprived, among children aged 24–59 months and 
65+ years, respectively.
Conclusions Higher rates of IAI hospitalisations and lower 
vaccine uptake in the most socioeconomically deprived 
populations suggest that health promotion policies and 
interventions that target these populations should be a priority.
bACkgrOunD 
Influenza is a highly infectious disease asso-
ciated with high morbidity and mortality 
rates among vulnerable populations world-
wide. Although influenza imposes a consider-
able burden on the National Health Service 
(NHS) in the UK, estimating the true burden 
of disease is difficult due to the non-specific 
symptomatic presentation of disease, and lack 
of laboratory confirmation. Using routinely 
collected healthcare system and mortality 
data, influenza was estimated to account for 
almost 900 000 general practitioner (GP) 
consultations, 25 000 hospitalisations, and 
20 000 deaths in England and Wales every 
year.1 However, several studies attempting 
to estimate the true burden of disease using 
different approaches and statistical model-
ling suggest that burden of illness attributable 
to influenza in the UK is likely to be under-
estimated by current surveillance systems.1–5 
Children <5 years of age, those aged 
65+ years, and individuals with underlying 
comorbidities are known to be at higher risk 
of complicated influenza.2 6 Socioeconomic 
strengths and limitations of this study
 ► The study uses routine public health data sources 
and a simple repeatable methodology, which can be 
applied to continue to monitor changes in incidence 
and vaccine uptake in local areas, and potentially 
evaluate targeted population-level interventions.
 ► We were unable to evaluate population-level im-
pact of influenza vaccines because of non-specific 
end points and seasonal disease variation over the 
study period.
 ► While an association with socioeconomic depriva-
tion was demonstrated for incidence of hospitalisa-
tion and uptake independently, difficulties linking 
data recorded through several incompatible data-
bases prevented integration and development of 
more complex models.
 ► Further research is needed to understand the at-
titudes and beliefs towards influenza disease and 
influenza vaccination as this will influence vaccine 
acceptability and uptake among the population.
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deprivation has also been associated with higher influen-
za-related mortality and hospitalisations.7–9 
Vaccination is the most effective control measure 
against complications of seasonal influenza. In the UK, 
the vaccine is offered free of charge through the NHS to 
those aged 65 years and over, and to individuals at risk of 
complicated influenza under 65 years of age. In 2013, the 
Department of Health (DH) expanded free vaccination 
to children with an age-phased rollout of an intranasal 
live attenuated influenza vaccine (LAIV) programme, 
that at the time of writing, includes all children aged 2–8 
years, and will eventually target all those up to 17 years 
of age.10 Children aged 2–4 years receive the vaccine at 
their general practice while those aged 5+ years are vacci-
nated at school. During the 2016/2017 influenza season, 
vaccine uptake in England was 70.5% among those aged 
65+ years, 36.9% among children aged 2–4 years, 48.6% in 
risk groups aged 6 months to 64 years, and 55.4% among 
children aged 5–8 years in school years 1–3.11 12 However, 
there is variation in uptake between GP practices and few 
practices achieve the 40% LAIV uptake target in children 
aged 2–4 years.13 There is an inverse association between 
deprivation and uptake of routine childhood vaccines 
(eg, vaccines for measles, mumps and rubella, human 
papillomavirus, influenza).14–16 Therefore, optimising 
vaccine delivery and identifying key target areas is neces-
sary to ensure the protection of those most vulnerable, 
and to maximise cost-effectiveness. Simulation studies 
supporting the decision to include LAIV in the vaccina-
tion schedule indicated that increasing vaccine uptake in 
children from 30% to 60% can markedly increase both 
direct and indirect protective effects of the vaccine.1 17 18 
However, these studies assume uniform vaccine coverage 
and fail to account for the substantial variation in disease 
risk and vaccine uptake observed across local areas with 
different socioeconomic status.15 Given that comorbid-
ities that increase the risk of adverse outcomes from 
influenza are substantially more prevalent among the 
most deprived populations,19 20 it would be expected that 
ensuring vaccine delivery to the most vulnerable groups 
would increase cost-effectiveness. Understanding how 
vaccine uptake varies across local areas with differing 
socioeconomic status, and correlating this to disease 
burden and use of healthcare resources, will provide 
evidence to inform immunisation policy and assist in 
developing targeted vaccine interventions to mitigate this 
effect. The aim of this study was to describe the burden of 
severe influenza-associated illness (IAI) in secondary care 
across local communities in a defined population in rela-
tion to small area level socioeconomic deprivation and 
vaccine uptake levels.
MEthODs
Population and setting
The study population was the metropolitan area of 
Merseyside, North-West England, defined in this study as 
the local authority areas of Halton, Knowsley, Liverpool, 
Sefton, St. Helens and Wirral. Merseyside has an esti-
mated resident population of 1.5 million,21 and is a diverse 
area that contains some of the most socioeconomically 
deprived neighbourhoods in England as well as some of 
the most affluent.22
Data sources
Influenza vaccine uptake
Influenza vaccine uptake data for seasons 2014/2015 and 
2015/2016 were obtained from ImmForm, the system 
used by the DH, the NHS and Public Health England 
(PHE) to record GP vaccination uptake.21 In addition 
to vaccine delivery through GPs, since 2015/2016 phar-
macies in England have also been able to offer influ-
enza vaccination.23 To capture these data, pharmacies 
are required to report any vaccine administration to the 
patients registered GP, and the GP will input this into the 
ImmForm system. We extracted aggregated information 
on vaccine uptake for all groups eligible for vaccination 
from 288 GP practices in Merseyside. Data included the 
number of eligible patients and the number of people 
receiving the vaccine for each eligible group.
Hospitalisations for influenza-associated illness
Hospitalisation data were extracted from the national 
Hospital Episode Statistics (HES) database via PHE, a 
records-based system maintained by NHS digital, which 
contains information on all hospital admissions, outpa-
tient appointments and A&E attendances covering all 
NHS trusts in England.
We extracted anonymised aggregated records of all 
patients residing in Merseyside admitted as an emergency 
to a hospital in England with a primary or subsequent diag-
nosis of acute respiratory illness identified between April 
2004 and March 2016. We used the International Statis-
tical Classification of Diseases and Related Health Prob-
lems (ICD-10) codes (J0*, J1*, J2*, J3*) to identify acute 
respiratory infection.2 We further used the ICD-10 coding 
to identify confirmed influenza, IAI and comorbidities. 
Confirmed influenza was identified by codes J09 and J10. 
IAI codes were selected using the following procedure 
and criteria:
 ► Literature search of peer-reviewed publications.2 24 25
 ► Identification of ICD-10 codes used by the NHS trusts 
as a primary diagnostic of respiratory diseases during 
the peak influenza season (December to March). We 
calculated means of daily usage during the peak influ-
enza compared with the rest of year and excluded 
codes, which had a daily usage ratio of <3 during the 
peak influenza season compared with the rest of the 
year.26
 ► Excluding specific ICD-10 codes which were iden-
tifying non-influenza-related illness, for example, 
J211-respiratory syncytial virus (RSV) pneumonia, 
J123-human metapneumovirus pneumonia and 
J301-allergic rhinitis due to pollen.
 ► Excluding ICD-10 codes (J218 and J219) commonly 
used for RSV. We identified these codes through a 
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prior study at a major acute care hospital in Merseyside 
by cross-checking patients with laboratory-confirmed 
RSV with their ICD-10 primary diagnosis code on 
discharge (Heinsbroek E, The impact of rotavirus 
vaccination on hospital pressures in a large paediatric 
hospital in the United Kingdom,  ClinicalTrials. gov 
NCT03271593).
Final selected ICD-10 codes for IAI were as follows: 
J06.9 (unspecified acute upper respiratory tract infec-
tion), J09 (influenza due to certain identified influenza 
virus), J10 (influenza due to other identified influenza 
virus), J11 (influenza, virus not identified), J12.8 (other 
viral pneumonia), J12.9 (viral pneumonia, unspecified), 
J22 (unspecified acute lower respiratory tract infection). 
ICD-10 codes used to identify comorbidities are listed 
in online supplementary S1-table 1, and were identified 
using the PHE Flu Plan 2016/2017 and Cromer et al.2 27
Area of residence, population denominators and socioeconomic 
deprivation
The HES dataset includes a code for neighbourhood 
area of residence, known as Lower Super Output Areas 
(LSOAs). There are 32 482 LSOAs in England, each 
containing approximately 1500 persons.21 These statis-
tical boundaries were constructed after the 2011 census, 
and have an associated measure of socioeconomic 
deprivation: the English Indices of Deprivation 2015, of 
which the Index of Multiple Deprivation (IMD) is the 
most commonly used. The IMD is a composite measure 
of social deprivation based on seven weighted domains: 
income; employment; health and disability; education 
skills and training; barriers to housing and other services; 
crime and living environment.22 Population denomina-
tors at LSOA and Middle Super Output Area (MSOA) 
were accessed for 2004–2015 by single year of age and 
sex and aggregated into the appropriate age categories 
referred to below. This information is published by the 
Office for National Statistics (ONS) and held by PHE.21
statistical analysis
Hospitalisation data from HES were recoded, reshaped 
and aggregated by age, sex, and time before merging to 
other data sources. Age categories were constructed based 
on age at hospitalisation: <24 months; 24–59 months; 
5–14 years; 15–39 years; 40–64 years; 65+ years.
To analyse the spatial and temporal changes in IAI 
hospitalisations, we constructed age-adjusted and sex-ad-
justed standardised incidence ratios (SIRs) for Merseyside 
at the MSOA level (approximately 5000–12 000 resident 
population) to avoid small numbers. SIRs that represent 
the relative risk of IAI hospitalisation in an MSOA were 
compared with the Merseyside average. To calculate SIRs, 
we first calculated the expected number of hospitalisa-
tions in each MSOAijk by calculating overall Merseyside 
rates for each combination of age j and sex k and multi-
plying these by corresponding MSOA population denom-
inators, as exampled in the following equation:
 
 
Expected numberijk =
MSOA populationjk
Total populationjk
×Total number of hospitalisationsjk 
 
Expected numbers are summed for each MSOA 
and SIRs are calculated by the ratio of the observed to 
expected numbers in each MSOA, as shown below:
  SIRi =
Observed number of hospitalisationsi
Expected number of hospitalisationsi   
We then produced choropleth maps of MSOA SIR for 
four 3-year pooled time periods for the area of Merseyside.
For analyses focusing on associations between socio-
economic deprivation and hospitalisation or uptake, we 
first constructed socioeconomic deprivation groups for 
IMD using quintiles of their score for LSOAs in England. 
In 2015, 45% of the population in Merseyside lived in 
the most deprived quintile.22 Association between socio-
economic status and IAI hospitalisations were assessed 
by fitting a negative binomial regression model (due to 
overdispersion) offset by resident population, adjusting 
for age group, sex and year-by-year variability in influenza 
incidence by including fiscal year. To examine the associ-
ation between age group and deprivation, an interaction 
term was also included. We also stratified by age group 
and incidence rate ratios (IRR) were calculated along 
with 95% CIs.
To estimate the association between socioeconomic 
deprivation and influenza vaccine uptake, uptake 
data were extracted at GP practice level. We used the 
LSOA level GP registered population, weighting vaccine 
uptake by proportion of population served by each GP 
practice, to create synthetic estimates of vaccine uptake 
at LSOA level for the 2014/2015 and 2015/2016 seasons. 
Vaccine uptake levels were classified into three catego-
ries in accordance with the national targets set by NHS 
England, DH and PHE27:
 ► Aged 24–59 months (target: 40%);
 ► Aged 65+ years (target: 75%);
 ► At-risk groups under 65 years of age (target: 55%).
The association between socioeconomic deprivation 
and vaccine uptake was assessed using fractional logit 
regression and robust SEs.28 The dependent variable 
was vaccine uptake, included as a proportion, and the 
independent variable was IMD quintile. The model was 
adjusted for fiscal year (April to March) and, because 
the unit of analysis was LSOA, the model was weighted 
using LSOA population size. Three separate models 
were constructed for vaccine uptake in those aged 
24–59 months, 65+ years and at-risk groups under 65 
years. The models enabled the calculation of ORs and 
robust 95% CIs.
Demographic characteristics were compared between 
those with and without clinical risk factors for severe IAI. 
Continuous variables were tested by Student’s t-test, or 
Wilcoxon rank-sum test if not normally distributed, and 
 χ2 -test or Fisher’s exact test were used for categorical 
variables.
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All data processing and statistical analyses were 
conducted using R V.3.2.3 or above.29
Patient and public involvement
Through our institute’s public involvement panel (PIP), 
the study team has had an ongoing dialogue on influ-
enza vaccine research. This research project was gener-
ated from these discussions as PIP members identified 
that reducing inequalities in influenza vaccine uptake 
should be a policy priority. The panel have considered 
and commented on the aims and objectives, and contrib-
uted to the development of this study. The findings from 
this study have been shared with organisations involved in 
data collection, patient contact and the PPI panel. Inves-
tigators have and will continue to present these findings 
at regional and national events and to participating NHS 
organisations (including lay membership), public health 
departments and government agencies.
rEsults
hospitalisations in Merseyside
Between April 2004 and March 2016, there were 89 058 
hospitalisation events coded as influenza or IAI in Mersey-
side (mean per year: 7421.5; 4.9 per 1000 population), 
of which 43 767 (49.1%) occurred among male patients 
(see online supplementary S1-table 2). The highest 
number of hospitalisations occurred in the 2006/2007 
season (n=9247; 6.2 per 1000 population), and the lowest 
in 2011/2012 (5231; 3.5 per 1000 population). Hospi-
talisations showed a clear seasonal pattern, peaking in 
December and January (figure 1). Most hospitalisations 
(n=29 887; 33.5%) corresponded to patients aged 65 years 
and over, or children under 24 months of age (n=21 420; 
24%). Over the study period, the mean population rate 
of hospitalisation was highest in children aged under 24 
months of age (51.3 per 1000) and 24–59 months of age 
(15.4 per 1000).
During the 2009/2010 influenza season, when the H1N1 
pandemic occurred, the proportion of hospitalisations 
corresponding to patients aged 65+ years was at its lowest 
(figure 1; online supplementary S1-table 2), reflecting the 
shift towards younger adults observed during the H1N1 
pandemic. Forty-eight per cent (n=42 712) of hospitalisa-
tion had an ICD-10 clinical code that indicated a comor-
bidity. The two most common comorbidities were heart 
disease (n=19 293; 45%) and chronic respiratory condi-
tions (n=15 755; 37%). The proportion of hospitalisations 
with comorbidities for complicated influenza increased 
with age, and was slightly greater in males (n=22 444; 
53%).
Association between hospitalisation rates and socioeconomic 
deprivation
Over half of the hospitalisations (n=47 008; 53%) 
occurred among those living in the most socioeconomi-
cally deprived quintile (table 1). Overall, the proportion 
of hospitalisations for IAI with a comorbidity was lower 
in the most deprived quintile (47%: n=22 167/47 008; 
p=0.01) compared with the least deprived (49%: 
n=2672/5454) (table 1). Regarding age group, a similar 
proportion of children aged <24 months (range: 6%–7%) 
and adults aged 65+ years (range 79%–81%) had comor-
bidities across the deprivation strata (table 1). However, 
among children aged 5–14 years and among those aged 
15–39 years and 40–64 years, the proportion of IAI hospi-
talisations that had a comorbidity was highest in the most 
deprived quintiles (table 1). Below the age of 5 years there 
was little difference in hospitalisation rates between the 
deprivation quintiles (figure 2), for example, the mean 
rate of IAI hospitalisations over the study period was 26.5 
per 1000 population in the most deprived quintile and 
31.4 per 1000 population in the least deprived. For chil-
dren aged 5–14 years, the risk of IAI hospitalisation was 
1.2 times among those from the most deprived compared 
with the least deprived (IRR 1.23; 95% CI 1.04 to 1.47; 
p=0.019). In those aged 15–39 years, the risk of hospital-
isation was over two times higher (IRR 2.08; 95% CI 1.76 
to 2.45; p<0.001) among residents in the most deprived 
areas in comparison to those in the least deprived quin-
tile; in adults aged 40–64 years, it was 2.6 times higher 
(IRR 2.65; 95% CI 2.35 to 2.99; p<0.001) and 1.9 times 
higher in those aged 65+ years (IRR 1.90; 95% CI 1.73 to 
2.10; p<0.001). When including an interaction term for 
the association between IMD quintile and age group, 
socioeconomic deprivation was strongly associated with 
an increased rate of hospitalisation in the 15–39, 40–64 
and 65+ years age group. Comparing the least deprived 
IMD quintile with the most deprived and those aged 
40–64 years with those aged <24 months, risk of hospital-
isation was nearly 2.4 times higher (IRR 2.39; 95% CI 1.94 
to 2.95; p<0.001) (see online supplementary S1-table 3). 
Spatially age-adjusted and sex-adjusted SIRs for IAI hospi-
talisations also show a visual association with deprivation 
over time, with higher rates being consistently observed 
in the most deprived areas (figure 3).
Influenza vaccine uptake
Vaccine uptake among children aged 2–4 years for the 
2014/2015 and 2015/2016 season did not attain the 
DH target of 40% in most of Merseyside (figure 4A). In 
2015/2016, 916/989 (93%) LSOAs did not meet the 40% 
target. Vaccine uptake among those aged 65+ years in the 
2015/2016 season was below the 75% DH target, with 
701/989 (71%) LSOA areas below the target (figure 4B). 
Among those presenting risk factors for complicated 
influenza, vaccine uptake in Merseyside was also below 
the DH target of 55%, with 853/989 (86%) LSOA areas 
not meeting the target in 2015/2016 (figure 4C). Vaccine 
uptake was lowest in the most socioeconomically deprived 
quintiles (figure 5). In the 2014/2015 and 2015/2016 
seasons, the odds of influenza vaccine uptake in the 
most deprived quintile compared with the least deprived 
were 30% lower in the 24–59 months group (OR 0.70; 
95% CI 0.66 to 0.74; p<0.001), 10% lower in the 65+ year 
age group (OR 0.90; 95% CI 0.88 to 0.92; p<0.001). In 
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at-risk groups, there was no major difference, 3% lower 
in most deprived (OR 1.00; 95% CI 0.98 to 1.04; p=0.66).
DIsCussIOn
This study shows variations in the number of hospitalisa-
tions for IAI in Merseyside, England, across the influenza 
seasons from 2004/2005 to 2015/2016, with a significant 
measurable difference by socioeconomic deprivation 
status in the adult population, which is in concordance 
with findings from other settings.8 30 31 Hospitalised IAI 
rates among those aged 40–64 years living in the most 
deprived communities were more than double those of 
the same age group from the most affluent areas. Influ-
enza vaccine uptake was below the national DH target 
among those aged <65 years presenting comorbidities, 
and while it was close to the 75% target for the 65+ years 
age group in 20014/2015, most of Merseyside was below 
target in 2015/2016.
In contrast to our findings among adults, IAI hospital-
isation rates among children <5 years of age were similar 
across socioeconomic strata, and vaccination uptake 
remained consistently below the 40% DH target for both 
Figure 1 Number of hospitalisations for influenza-associated illness among Merseyside residents, 2004/2005–2015/2016, by 
month and age group. m, months; y, years.
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2014/2015 and 2015/2016 seasons. It could be hypoth-
esised that in childhood, in the absence of comorbid-
ities that could exacerbate the disease, hospitalisation 
following exposure to the influenza virus is likely to be 
driven by factors other than social determinants of health. 
While there is robust evidence indicating that social and 
economic disadvantage is strongly associated with the 
development of ill-health in childhood and in later life,32 
our results suggest that hospitalisations for infectious 
respiratory diseases, such as influenza illness, are an equal 
threat to very young children regardless of their socioeco-
nomic background, which is likely to be related to there 
Figure 2 Incidence rate ratios of influenza-associated illness (IAI) hospitalisation rate for Index of Multiple Deprivation 
quintiles 1 (most deprived)−4 compared with a reference group of the least deprived quintile (5) by age group. Rate ratios for IAI 
hospitalised incidence rates were estimated with negative binomial regression stratified by age group. Models were additionally 
adjusted for sex and fiscal year. m, months; y, years. *p<0.05, **p<0.01, ***p<0.001. 
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being less of a differential in comorbidities across depri-
vation strata at a young age.
While data on vaccine uptake was not available for 
influenza seasons prior to 2014/2015, hospitalisation 
rates have followed a consistent pattern throughout the 
study period, with an age-shift observed in the 2009/2010 
season, consistent with the H1N1 pandemic.33 Consis-
tent failure to attain the DH vaccination targets across all 
eligible groups warrant further investigations. Accessibility 
to vaccination, knowledge and perceptions of both vacci-
nation and disease, are critical aspects for explaining and 
tackling low uptake of influenza vaccination. The inter-
action and relative importance of these issues will vary 
between populations, and will differ between adults and 
children. There is evidence that individuals at high risk of 
complicated influenza infection do not perceive themselves 
to be susceptible to influenza illness, and that they have 
concerns over adverse effects of vaccination,34–36 which 
suggest that providing knowledge and education about 
influenza disease to high-risk groups will be crucial for any 
interventions attempting to improve vaccine uptake. Our 
findings further highlight the need for informed targeted 
interventions addressing low vaccine uptake among chil-
dren and individuals at risk of complicated influenza to 
ensure national vaccination targets are met in coming 
years. The lower vaccine uptake rates observed among the 
most socioeconomically deprived populations compared 
the most affluent ones suggest that interventions should 
prioritise areas where vaccine uptake is low and hospi-
talisation rates are high. Vaccination with the seasonal 
Figure 3 Age-adjusted and sex-adjusted standardised incidence ratios for influenza-associated illness hospitalisations 
for Merseyside residents by Middle Super Output Area and pooled years, 2004/2005–2015/2016. IMD, Index of Multiple 
Deprivation. 
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influenza vaccine can induce long-term cross-reactive 
antibodies that could have a protective effect in the event 
of an influenza pandemic.37 38 Highlighting this added 
benefit of the vaccine could potentially have a positive 
influence in people’s perception of influenza vaccine, and 
contribute to improve vaccine uptake.
The strongest association between IAI hospitalisation 
and deprivation was seen among those aged 40–64 years. 
This could be in great part explained by the fact that 
unhealthy behaviours (eg, smoking, alcohol abuse) and 
environmental risk factors (eg, poor living environment) 
are associated with lower socioeconomic status. These 
factors will contribute cumulatively to comorbidities over 
time peaking in middle to old age,39 and will, in turn, have 
a negative impact in on life expectancy, which is lower 
in deprived areas.40 While, vaccine uptake in vaccine-el-
igible patients aged 65+ years is significantly higher 
than in those at risk aged 40–64 years, the association 
between IAI hospitalisation and deprivation is still clearly 
present, although slightly less pronounced. Interventions 
designed with the aim of improving the overall health 
and quality of life of the adults in the most socioeconom-
ically deprived populations can potentially contribute to 
a reduction in IAI.41
limitations
Reliance on ICD-10 codes for the identification of IAI is 
an important limitation to our study. While we can assume 
that ICD-10 coding for confirmed influenza denotes labo-
ratory confirmation, many hospitalised influenza cases 
will be unconfirmed by laboratory diagnostics and are 
likely to receive a symptom-based ICD-10 diagnosis code 
on discharge. Consequently, the true burden of influenza 
hospitalisations could be higher or lower than our esti-
mations. The use of a seasonal usage ratio to help identify 
ICD-10 codes associated with IAI was identified a priori 
through professional consultation but unvalidated 
against a gold standard diagnostic. However, the selection 
of ICD-10 codes used for this study was carefully assessed 
and informed by previous studies,2 24 25 in an attempt 
to minimise misclassification. Crucially for the research 
aims, variations in coding over time were not observed, 
nor are they likely to be influenced by the socioeconomic 
background of the patient, since we used data from the 
national health system. Therefore, we are reassured that 
the observed association and direction of the effect have 
not been affected by using ICD-10 coding.
Another important limitation identified in this study is 
the fact that information is recorded in several databases 
throughout the health system without common iden-
tifiers to enable the data linkage of individuals. While 
hospitalisation data could be identified to LSOA level 
through HES, vaccine uptake could only be obtained at 
GP practice level through ImmForm, and was syntheti-
cally estimated at LSOA level. Moreover, none of these 
Figure 4 Influenza vaccine uptake by Lower Super Output Area (LSOA) 2014/2015 and 2015/2016 seasons in those aged 
(A) 24–59 months (40% NHS England target); (B) 65+ years (75% NHS England target); (C) at-risk groups aged 6 months to 64 
years (55% NHS England target). Each block represents 1 of 989 LSOAs in Merseyside.
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databases are linked to laboratory information. While the 
correlation with socioeconomic deprivation was demon-
strated for both outcomes, and is apparent in our graphic 
representations, this limitation prevented the develop-
ment of more complex spatiotemporal Bayesian hierar-
chical models. In order to evaluate interventions aimed 
at improving vaccine uptake and reducing the burden of 
hospitalisations due to IAI, surveillance data on disease 
incidence, hospitalisations and vaccine uptake should be 
recorded in a systematic and consistent manner over time 
to facilitate comparison before and after the interven-
tion was implemented. A surveillance system facilitating 
record matching between the various existing databases 
and the incorporation of laboratory data would facilitate 
Figure 5 OR of vaccine uptake by Index of Multiple Deprivation quintiles 1 (most deprived)−4 compared with a reference 
group of the least deprived quintile (5) by age group, 2014/2015–2015/2016. Adjusted ORs for vaccine uptake were estimated 
with general linear models of the binomial family with a logit function, robust SEs were used to calculate 95% CIs. Models were 
additionally adjusted for fiscal year and weighted using the relevant age-related population of each Lower Super Output Area. 
m, months; y, years. *P<0.05, **p<0.01, ***p<0.001. 
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recording disease trends and the identification of any 
changes in disease epidemiology, naturally or as a conse-
quence of a public health intervention.
Finally, while our study has been able to demonstrate the 
association between socioeconomic deprivation and IAI 
hospitalisations, and with lower vaccine uptake, the results 
cannot elucidate the underlying causes for this observa-
tion. Comorbidities exacerbate respiratory disease,6 and 
socially deprived areas tend to have more limited access 
to social resources, resulting in poorer health outcomes.42 
Therefore, designing effective vaccine policy and public 
health interventions that translate outcomes to health 
equity is critical; and requires improved understanding of 
the healthcare system engagement that underpins lower 
influenza vaccine uptake.43
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